FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2186449314> ?p ?o ?g. }

• W2186449314 endingPage "227" @default.
• W2186449314 startingPage "216" @default.
• W2186449314 abstract "Circulating microRNAs (miRNAs) have emerged as novel biomarkers of diabetes. The current study focuses on the role of circulating miRNAs in patients with type 1 diabetes and their association with diabetic retinopathy. A total of 29 miRNAs were quantified in serum samples (n = 300) using a nested case-control study design in two prospective cohorts of the DIabetic REtinopathy Candesartan Trial (DIRECT): PROTECT-1 and PREVENT-1. The PREVENT-1 trial included patients without retinopathy at baseline; the PROTECT-1 trial included patients with nonproliferative retinopathy at baseline. Two miRNAs previously implicated in angiogenesis, miR-27b and miR-320a, were associated with incidence and with progression of retinopathy: the odds ratio per SD higher miR-27b was 0.57 (95% CI 0.40, 0.82; P = 0.002) in PREVENT-1, 0.78 (0.57, 1.07; P = 0.124) in PROTECT-1, and 0.67 (0.50, 0.92; P = 0.012) combined. The respective odds ratios for higher miR-320a were 1.57 (1.07, 2.31; P = 0.020), 1.43 (1.05, 1.94; P = 0.021), and 1.48 (1.17, 1.88; P = 0.001). Proteomics analyses in endothelial cells returned the antiangiogenic protein thrombospondin-1 as a common target of both miRNAs. Our study identifies two angiogenic miRNAs, miR-320a and miR-27b, as potential biomarkers for diabetic retinopathy." @default.
• W2186449314 created "2016-06-24" @default.
• W2186449314 creator A5009628835 @default.
• W2186449314 creator A5012684500 @default.
• W2186449314 creator A5017327595 @default.
• W2186449314 creator A5041864981 @default.
• W2186449314 creator A5058837981 @default.
• W2186449314 creator A5061059098 @default.
• W2186449314 creator A5061631272 @default.
• W2186449314 creator A5062596666 @default.
• W2186449314 creator A5085592050 @default.
• W2186449314 creator A5088028330 @default.
• W2186449314 date "2015-09-22" @default.
• W2186449314 modified "2023-10-16" @default.
• W2186449314 title "Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes" @default.
• W2186449314 cites W1964757399 @default.
• W2186449314 cites W1966515321 @default.
• W2186449314 cites W1969303603 @default.
• W2186449314 cites W1972651881 @default.
• W2186449314 cites W1980888291 @default.
• W2186449314 cites W1983370580 @default.
• W2186449314 cites W1987126756 @default.
• W2186449314 cites W1995767058 @default.
• W2186449314 cites W2015547750 @default.
• W2186449314 cites W2020758879 @default.
• W2186449314 cites W2026686857 @default.
• W2186449314 cites W2027777245 @default.
• W2186449314 cites W2031493375 @default.
• W2186449314 cites W2046659221 @default.
• W2186449314 cites W2058767592 @default.
• W2186449314 cites W2072190764 @default.
• W2186449314 cites W2080722753 @default.
• W2186449314 cites W2082867958 @default.
• W2186449314 cites W2084228496 @default.
• W2186449314 cites W2086620251 @default.
• W2186449314 cites W2098170672 @default.
• W2186449314 cites W2101839496 @default.
• W2186449314 cites W2110788884 @default.
• W2186449314 cites W2111188992 @default.
• W2186449314 cites W2112760185 @default.
• W2186449314 cites W2120294503 @default.
• W2186449314 cites W2126493135 @default.
• W2186449314 cites W2126930838 @default.
• W2186449314 cites W2130154562 @default.
• W2186449314 cites W2133863555 @default.
• W2186449314 cites W2134408498 @default.
• W2186449314 cites W2138881995 @default.
• W2186449314 cites W2143570364 @default.
• W2186449314 cites W2144385056 @default.
• W2186449314 cites W2146105386 @default.
• W2186449314 cites W2147958126 @default.
• W2186449314 cites W2155912199 @default.
• W2186449314 cites W2155965977 @default.
• W2186449314 cites W2157454492 @default.
• W2186449314 cites W2160554864 @default.
• W2186449314 cites W2160741229 @default.
• W2186449314 cites W2161068194 @default.
• W2186449314 doi "https://doi.org/10.2337/db15-0389" @default.
• W2186449314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26395742" @default.
• W2186449314 hasPublicationYear "2015" @default.
• W2186449314 type Work @default.
• W2186449314 sameAs 2186449314 @default.
• W2186449314 citedByCount "94" @default.
• W2186449314 countsByYear W21864493142016 @default.
• W2186449314 countsByYear W21864493142017 @default.
• W2186449314 countsByYear W21864493142018 @default.
• W2186449314 countsByYear W21864493142019 @default.
• W2186449314 countsByYear W21864493142020 @default.
• W2186449314 countsByYear W21864493142021 @default.
• W2186449314 countsByYear W21864493142022 @default.
• W2186449314 countsByYear W21864493142023 @default.
• W2186449314 crossrefType "journal-article" @default.
• W2186449314 hasAuthorship W2186449314A5009628835 @default.
• W2186449314 hasAuthorship W2186449314A5012684500 @default.
• W2186449314 hasAuthorship W2186449314A5017327595 @default.
• W2186449314 hasAuthorship W2186449314A5041864981 @default.
• W2186449314 hasAuthorship W2186449314A5058837981 @default.
• W2186449314 hasAuthorship W2186449314A5061059098 @default.
• W2186449314 hasAuthorship W2186449314A5061631272 @default.
• W2186449314 hasAuthorship W2186449314A5062596666 @default.
• W2186449314 hasAuthorship W2186449314A5085592050 @default.
• W2186449314 hasAuthorship W2186449314A5088028330 @default.
• W2186449314 hasBestOaLocation W21864493141 @default.
• W2186449314 hasConcept C120665830 @default.
• W2186449314 hasConcept C121332964 @default.
• W2186449314 hasConcept C126322002 @default.
• W2186449314 hasConcept C134018914 @default.
• W2186449314 hasConcept C143998085 @default.
• W2186449314 hasConcept C156957248 @default.
• W2186449314 hasConcept C188816634 @default.
• W2186449314 hasConcept C2777180221 @default.
• W2186449314 hasConcept C2778313320 @default.
• W2186449314 hasConcept C2779829184 @default.
• W2186449314 hasConcept C555293320 @default.
• W2186449314 hasConcept C60644358 @default.
• W2186449314 hasConcept C61511704 @default.
• W2186449314 hasConcept C71924100 @default.
• W2186449314 hasConcept C86803240 @default.

• next